Tema Etfs LLC Has $3.22 Million Stock Holdings in Danaher Corporation $DHR

Tema Etfs LLC raised its holdings in Danaher Corporation (NYSE:DHRFree Report) by 211.4% during the third quarter, Holdings Channel reports. The institutional investor owned 16,256 shares of the conglomerate’s stock after buying an additional 11,035 shares during the quarter. Tema Etfs LLC’s holdings in Danaher were worth $3,223,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Philip James Wealth Mangement LLC acquired a new stake in shares of Danaher in the 3rd quarter worth about $387,000. Sachetta LLC raised its stake in shares of Danaher by 3.2% in the third quarter. Sachetta LLC now owns 2,183 shares of the conglomerate’s stock worth $433,000 after purchasing an additional 68 shares during the last quarter. Sonoma Allocations LLC purchased a new stake in shares of Danaher in the third quarter worth approximately $264,000. World Equity Group Inc. lifted its holdings in shares of Danaher by 9.6% in the third quarter. World Equity Group Inc. now owns 4,686 shares of the conglomerate’s stock valued at $929,000 after purchasing an additional 410 shares in the last quarter. Finally, MASTERINVEST Kapitalanlage GmbH boosted its position in shares of Danaher by 10.2% during the third quarter. MASTERINVEST Kapitalanlage GmbH now owns 9,741 shares of the conglomerate’s stock valued at $1,931,000 after buying an additional 903 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR opened at $238.28 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The firm has a market cap of $168.31 billion, a PE ratio of 49.13, a PEG ratio of 4.24 and a beta of 0.89. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The stock’s fifty day moving average price is $225.77 and its two-hundred day moving average price is $210.67.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company’s revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.71 earnings per share. On average, equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Activity

In related news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Rothschild & Co Redburn reiterated a “neutral” rating and issued a $220.00 target price (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Barclays boosted their price target on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Finally, Evercore ISI reiterated an “outperform” rating and issued a $250.00 price objective on shares of Danaher in a research note on Monday, January 5th. Twenty-one equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $249.92.

Read Our Latest Stock Analysis on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.